Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

26. Psychopharmacological Treatments 611Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. Am JDrug Alcohol Abuse, 13, 1–17.Koe, B. K. (1976). Molecular geometry of inhibitors of the uptake of catecholaminesand serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther, 199,649–661.Kosten, T. A. (1997). Enhanced neurobehavioral effects of cocaine with chronicneuroleptic exposure in rats. Schizophr Bull, 23, 203–213.Kosten, T. R., & Kleber, H. D. (1984). Strategies to improve compliance with narcoticantagonists. Am J Drug Alcohol Abuse, 10, 249–266.Kosten, T. R., & Kleber, H. D. (1988). Buprenorphine detoxification from opioiddependence: A pilot study. Life Sci, 42, 635–641.Kosten, T. R., Krystal, J. H., Charney, D. S., Price, L. H., Morgan, C. H., & Kleber, H.D. (1989). Rapid detoxication from opioid dependence. Am J Psychiatry, 146,1349.Kosten, T. R., & O’Connor, P. G. (2003). Current concepts—management of drugwithdrawal. N Engl J Med, 348, 1786–1795.Kosten, T. R., Rosen, M., Bond, J., Settles, M., St. Clair Roberts, J., Shields, J., et al.(2002). Human therapeutic cocaine vaccine: Safety and immunogenicity. Vaccine,20, 1196–1204.Kosten, T. R., & Ziedonis, D. M. (1997). Substance abuse and schizophrenia. SchizophrBull, 23, 181–186.Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J., &Bohn, M. (1994). Bupsirone treatment of anxious alcoholics. Arch Gen Psychiatry,51, 720–731.Lawental, E. (2000). Ultra rapid opiate detoxification as compared to 30-day inpatientdetoxification program—a retrospective follow-up study. J Subst Abuse, 11, 173–181.Lee, E. W., & D’Alonzo, G. E. (1993). Cigarette smoking, nicotine addiction, and itspharmacologic treatment. Arch Intern Med, 153, 34–48.Lewis, J. W. (1985). Buprenorphine. Drug Alcohol Depend, 14, 363–372.Littleton, J. (1995). Acamprosate in alcohol dependence: How does it work? Addiction,90, 1179–1188.Malcolm, R., Ballenger, J. C., Sturgis, E. T., & Anton, R. (1989). Double-blind controlledtrial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.Am J Psychiatry, 146, 617–621.Malcolm, R., Myrick, H., Brady, K. T., & Ballenger, J. C. (2001). Update onanticonvulsants for the treatment of alcohol withdrawal. Am J Addict, 10(Suppl),16–23.Malcolm, R., Myrick, H., Roberts, J., Wang, W., Anton, R. F., & Ballenger, J. C.(2002). The effects of carbamazepine and lorazepam on single versus multiple previousalcohol withdrawals in an outpatient randomized trial. J Gen Intern Med, 17,349–355.Mason, B. (2001). Treatment of alcohol-dependent outpatients with acamprosate: Aclinical review. J Clin Psychiatry, 62(Suppl), 42–48.Mason, B., & Ownby, R. (2000). Acamprosate for the treatment of alcohol dependence:A review of double-blind, placebo-controlled trials. CNS Spectrum, 5, 58–69.